Atovaquone Suspension
Product Images NDC 0121-0956

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 0121-0956). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C:\users\admin\desktop\new Folder (3)\image2.jpg (Atovaquone Os 1)

Chemical structure of Atovaquone, showing its molecular arrangement including a chlorophenyl group attached to a cyclohexane ring and a hydroxynaphthoquinone moiety.*

FDA Label Image

Atovaquone Oral Suspension-750 mg/5ml-label (Atovaquone Os 2)

Atovaquone Oral Suspension USP 750 mg/5 mL in a 210 mL bottle labeled by PAI Holdings, LLC dba PAI Pharma. The label includes dosage instructions, storage conditions, and a warning not to use if the shrink band is broken or missing. It is designated for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.